TY - JOUR
T1 - Coronary Vasomotor Abnormalities in Insulin-Resistant Individuals
AU - Quiñones, Manuel J.
AU - Hernandez-Pampaloni, Miguel
AU - Schelbert, Heinrich
AU - Bulnes-Enriquez, Isabel
AU - Jimenez, Xochitl
AU - Hernandez, Gustavo
AU - De La Rosa, Roxana
AU - Chon, Yun
AU - Yang, Hulying
AU - Nicholas, Susanne B.
AU - Modilevsky, Tamara
AU - Yu, Katherine
AU - Van Herle, Katja
AU - Castellani, Lawrence W.
AU - Elashoff, Robert
AU - Hsueh, Willa A.
PY - 2004/5/4
Y1 - 2004/5/4
N2 - Background: Insulin resistance is a metabolic spectrum that progresses from hyperinsulinemia to the metabolic syndrome, impaired glucose tolerance, and finally type 2 diabetes mellitus. It is unclear when vascular abnormalities begin in this spectrum of metabolic effects. Objective: To evaluate the association of insulin resistance with the presence and reversibility of coronary vasomotor abnormalities in young adults at low cardiovascular risk. Design: Cross-sectional study followed by prospective, open-label treatment study. Setting: University hospital. Patients: 50 insulin-resistant and 22 insulin-sensitive, age-matched Mexican-American participants without glucose intolerance or traditional risk factors for or evidence of coronary artery disease. Intervention: 3 months of thiazolidinedione therapy for 25 insulin-resistant patients. Measurements: Glucose infusion rate in response to insulin infusion was used to define insulin resistance (glucose infusion rate ≤ 4.00 mg/kg of body weight per minute [range, 0.90 to 3.96 mg/kg per minute]) and insulin sensitivity (glucose infusion rate ≥ 7.50 mg/kg per minute [range, 7.52 to 13.92 mg/kg per minute]). Myocardial blood flow was measured by using positron emission tomography at rest, during cold pressor test (largely endothelium-dependent), and after dipyridamole administration (largely vascular smooth muscle-dependent). Results: Myocardial blood flow responses to dipyridamole were similar in the Insulin-sensitive and insulin-resistant groups. However, myocardial blood flow response to cold pressor test increased by 47.6% from resting values in insulin-sensitive patients and by 14.4% in insulin-resistant patients. During thiazolidinedione therapy in a subgroup of insulin-resistant patients, insulin sensitivity improved, fasting plasma insulin levels decreased, and myocardial blood flow responses to cold pressor test normalized. Limitations: The study was not randomized, and it included only 1 ethnic group. Conclusions: Insulin-resistant patients who do not have hypercholesterolemia or hypertension and do not smoke manifest coronary vasomotor abnormalities. Insulin-sensitizing thiazolidinedione therapy normalized these abnormalities. These results suggest an association between insulin resistance and abnormal coronary vasomotor function, a relationship that requires confirmation in larger studies.
AB - Background: Insulin resistance is a metabolic spectrum that progresses from hyperinsulinemia to the metabolic syndrome, impaired glucose tolerance, and finally type 2 diabetes mellitus. It is unclear when vascular abnormalities begin in this spectrum of metabolic effects. Objective: To evaluate the association of insulin resistance with the presence and reversibility of coronary vasomotor abnormalities in young adults at low cardiovascular risk. Design: Cross-sectional study followed by prospective, open-label treatment study. Setting: University hospital. Patients: 50 insulin-resistant and 22 insulin-sensitive, age-matched Mexican-American participants without glucose intolerance or traditional risk factors for or evidence of coronary artery disease. Intervention: 3 months of thiazolidinedione therapy for 25 insulin-resistant patients. Measurements: Glucose infusion rate in response to insulin infusion was used to define insulin resistance (glucose infusion rate ≤ 4.00 mg/kg of body weight per minute [range, 0.90 to 3.96 mg/kg per minute]) and insulin sensitivity (glucose infusion rate ≥ 7.50 mg/kg per minute [range, 7.52 to 13.92 mg/kg per minute]). Myocardial blood flow was measured by using positron emission tomography at rest, during cold pressor test (largely endothelium-dependent), and after dipyridamole administration (largely vascular smooth muscle-dependent). Results: Myocardial blood flow responses to dipyridamole were similar in the Insulin-sensitive and insulin-resistant groups. However, myocardial blood flow response to cold pressor test increased by 47.6% from resting values in insulin-sensitive patients and by 14.4% in insulin-resistant patients. During thiazolidinedione therapy in a subgroup of insulin-resistant patients, insulin sensitivity improved, fasting plasma insulin levels decreased, and myocardial blood flow responses to cold pressor test normalized. Limitations: The study was not randomized, and it included only 1 ethnic group. Conclusions: Insulin-resistant patients who do not have hypercholesterolemia or hypertension and do not smoke manifest coronary vasomotor abnormalities. Insulin-sensitizing thiazolidinedione therapy normalized these abnormalities. These results suggest an association between insulin resistance and abnormal coronary vasomotor function, a relationship that requires confirmation in larger studies.
UR - https://www.scopus.com/pages/publications/2342466765
U2 - 10.7326/0003-4819-140-9-200405040-00009
DO - 10.7326/0003-4819-140-9-200405040-00009
M3 - Article
C2 - 15126253
AN - SCOPUS:2342466765
SN - 0003-4819
VL - 140
SP - 700-708+I32
JO - Annals of Internal Medicine
JF - Annals of Internal Medicine
IS - 9
ER -